Skip to main content

Table 2 Group (SMA vs DLPFC rTMS) charactristics

From: Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study

Variable Category n rTMS protocol p-value 95%CI
SMA rTMS DLPFC rTMS lower upper
SMA DLPFC SMA DLPFC
Sample size (n)   65 38 27      
Comorbidity (n)   34 20 14 0.09     
On medication (n)   51 21 30 0.77     
rTMS reponse Yes 30 21 9 0.12     
No 35 17 18      
Age Mean (SD) 32.25 (10.23) 31.58 (10.64) 33.19 (9.75) 0.54 27.03 39.49 33.00 44.38
Gender Male 30 17 13 0.80     
Female 35 21 14      
Education Diploma or lower 24 14 10 0.89     
Associate degree 7 4 3      
Bachelor degree 22 13 9      
Masters degree 6 3 3      
Not reported 6 4 2      
Marital status Single 26 15 11 0.94     
Married 33 20 13      
Divorced or separated 6 3 3      
BL Y-BOCS Mean (SD) 22.75 (6.66) 23.52 (7.37) 21.66 (5.44) 0.27 18.74 26.52 17.07 23.88
BL BAI Mean (SD) 25.90 (11.01) 24.71 (10.15) 27.59 (12.10) 0.32 20.19 30.74 20.47 33.83
BL BDI-II Mean (SD) 22.64 (8.95) 21.84 (9.86) 23.77 (7.54) 0.39 18.36 27.07 21.70 29.98
  1. Note: SMA Supplementary motor area, rTMS repetitive transcranial magnetic stimulation, DLPFC dorsolateral prefrontal cortex, SD Standard Deviation, Y-BOCS Yale-Brown Obsessive-Compulsive Scale, BAI Beck Anxiety Inventory, BDI-II Beck Depression Inventory; Group differences based on the applied protocol (SMA vs DLPFC rTMS) in demographic variables were explored using chi-square analysis or Fisher’s exact test for categorical variables and t-tests for continuous variables